These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 28008906)
1. Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53. Chao T; Zhou X; Cao B; Liao P; Liu H; Chen Y; Park HW; Zeng SX; Lu H Nat Commun; 2016 Dec; 7():13755. PubMed ID: 28008906 [TBL] [Abstract][Full Text] [Related]
2. XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313. Lee MG; Han J; Jeong SI; Her NG; Lee JH; Ha TK; Kang MJ; Ryu BK; Chi SG Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15532-7. PubMed ID: 25313037 [TBL] [Abstract][Full Text] [Related]
3. Augmented antitumor activity of 5-fluorouracil by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells. Imanishi M; Yamamoto Y; Wang X; Sugaya A; Hirose M; Endo S; Natori Y; Yamato K; Hyodo I Cancer Sci; 2019 Feb; 110(2):639-649. PubMed ID: 30488540 [TBL] [Abstract][Full Text] [Related]
4. Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions. Gopal YN; Chanchorn E; Van Dyke MW Mol Cancer Ther; 2009 Mar; 8(3):552-62. PubMed ID: 19276167 [TBL] [Abstract][Full Text] [Related]
5. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop. Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750 [TBL] [Abstract][Full Text] [Related]
6. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function. Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313 [TBL] [Abstract][Full Text] [Related]
7. DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties. Soares J; Espadinha M; Raimundo L; Ramos H; Gomes AS; Gomes S; Loureiro JB; Inga A; Reis F; Gomes C; Santos MMM; Saraiva L Mol Oncol; 2017 Jun; 11(6):612-627. PubMed ID: 28296148 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of MDM2 inhibitor MI-219 against lung cancer cells alone or in combination with MDM2 knockdown, a XIAP inhibitor or etoposide. Zheng M; Yang J; Xu X; Sebolt JT; Wang S; Sun Y Anticancer Res; 2010 Sep; 30(9):3321-31. PubMed ID: 20944104 [TBL] [Abstract][Full Text] [Related]
9. Inhibiting the p53-MDM2 interaction: an important target for cancer therapy. Chène P Nat Rev Cancer; 2003 Feb; 3(2):102-9. PubMed ID: 12563309 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of p53 by phosphatase of regenerating liver 3 is mediated by MDM2 and PIRH2. Min SH; Kim DM; Heo YS; Kim HM; Kim IC; Yoo OJ Life Sci; 2010 Jan; 86(1-2):66-72. PubMed ID: 19945467 [TBL] [Abstract][Full Text] [Related]
12. Gossypol has anti-cancer effects by dual-targeting MDM2 and VEGF in human breast cancer. Xiong J; Li J; Yang Q; Wang J; Su T; Zhou S Breast Cancer Res; 2017 Mar; 19(1):27. PubMed ID: 28274247 [TBL] [Abstract][Full Text] [Related]
13. Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53-MDM2 interaction. Soares J; Pereira NA; Monteiro Â; Leão M; Bessa C; Dos Santos DJ; Raimundo L; Queiroz G; Bisio A; Inga A; Pereira C; Santos MM; Saraiva L Eur J Pharm Sci; 2015 Jan; 66():138-47. PubMed ID: 25312347 [TBL] [Abstract][Full Text] [Related]
14. The regulation of MDM2 by multisite phosphorylation--opportunities for molecular-based intervention to target tumours? Meek DW; Hupp TR Semin Cancer Biol; 2010 Feb; 20(1):19-28. PubMed ID: 19897041 [TBL] [Abstract][Full Text] [Related]
15. Knockdown of FAM3B triggers cell apoptosis through p53-dependent pathway. Mou H; Li Z; Yao P; Zhuo S; Luan W; Deng B; Qian L; Yang M; Mei H; Le Y Int J Biochem Cell Biol; 2013 Mar; 45(3):684-91. PubMed ID: 23246487 [TBL] [Abstract][Full Text] [Related]
16. HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53. Wang Y; Hu L; Wang J; Li X; Sahengbieke S; Wu J; Lai M J Pathol; 2018 Dec; 246(4):508-518. PubMed ID: 30175854 [TBL] [Abstract][Full Text] [Related]
17. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation. Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825 [TBL] [Abstract][Full Text] [Related]
18. Abrogation of Gli3 expression suppresses the growth of colon cancer cells via activation of p53. Kang HN; Oh SC; Kim JS; Yoo YA Exp Cell Res; 2012 Mar; 318(5):539-49. PubMed ID: 22227409 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of RNF2 induces apoptosis by regulating MDM2 and p53 stability. Wen W; Peng C; Kim MO; Ho Jeong C; Zhu F; Yao K; Zykova T; Ma W; Carper A; Langfald A; Bode AM; Dong Z Oncogene; 2014 Jan; 33(4):421-8. PubMed ID: 23318437 [TBL] [Abstract][Full Text] [Related]
20. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein. Landers JE; Cassel SL; George DL Cancer Res; 1997 Aug; 57(16):3562-8. PubMed ID: 9270029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]